Medtronic had large options trading on Dec. 29, with 16,512 call options on the company purchased, according to The Legacy. This is a 119 percent increase on the daily volume. Additionally, Vice President Richard Kuntz sold 12,855 shares at a total value of $958,211.70.
Stryker Director Ronda E. Stryker sold 28,000 shares of the company’s stock on Dec. 29 for a total transaction of $2.6 million, according to a WKRB News & Analysis report. She now owns 174,605 shares, totaling $16.59 million. The company’s stock spiked around Christmas when rumors resurfaced about Stryker’s plan to acquire Smith & Nephew.
NuVasive shareholder Patrick Miles sold 15,000 shares of the company’s stock on the open market on Dec. 24 for a total transaction of $712,800. He now owns 47,501 shares valued at around $2.2 million, according to a Ticker Report article. COO Keith Valentine earlier sold 5,893 shares on Dec. 19 for a total transaction of $281,567.54, according to a Dakota Financial News report.
Smith & Nephew shares were upgraded to “outperform” by Zacks from a neutral rating, according to a report from The Legacy. The firm has a $40.90 price target on the stock, indicating a potential upside of 6.18 percent.
K2M hit another 52-week high on Dec. 24, peaking at $23.63, according to an Equities report. The stock opened at $20.71 and closed the day at $20.53. The new high could mean “trading opportunities on either the long or short side.”
More articles on orthopedic devices:
12 key observations on orthopedic device company stock—Zimmer, Medtronic & Stryker
Zyga Technology raises $2M in equity-and-options round
Medtronic, K2M, Stryker & more—5 key notes
